(NASDAQ: ICLR) Icon's forecast annual revenue growth rate of 8.67% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 11.67%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.08%.
Icon's revenue in 2023 is $7,664,505,000.On average, 4 Wall Street analysts forecast ICLR's revenue for 2023 to be $681,158,660,553, with the lowest ICLR revenue forecast at $677,141,381,243, and the highest ICLR revenue forecast at $687,181,397,805. On average, 3 Wall Street analysts forecast ICLR's revenue for 2024 to be $739,808,882,600, with the lowest ICLR revenue forecast at $735,686,362,026, and the highest ICLR revenue forecast at $742,058,598,173.
In 2025, ICLR is forecast to generate $793,070,425,613 in revenue, with the lowest revenue forecast at $793,070,425,613 and the highest revenue forecast at $793,070,425,613.